Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Last year annual results were published at end of February and anticipate similar timing so hopefully 4 -5 weeks max before we get an update from Nigel - if nothing positive before then I suspect we will get some vague waffle accompanying results telling us “this time next year we’ll be millionaires Rodney !”
With all the positive news on approved COVID vaccines and imminent rollouts , does anyone else feel that the COVID ship has sailed for N4P but Nuvec is still a great opportunity for longer term holders and is a bargain price at movement . My thoughts are that it could drop to 5p if no positive news so roughly 40% risk but could easily see 20p so 125% upside if a commercial deal could be agreed . Happy new year to all my fellow N4P holders and let’s hope it’s a prosperous one .
This share has huge potential but we need a positive update from Nigel and his buddies at Angel showing real progress if we are to see any significant upside . New mutations , rates of cancer etc don’t matter if N4P can’t deliver anything to help them . Small gains are worth more than big promises !
Where do people see the year ending for N4p Looking forward to 2021 does anyone know when we can expect a firm update, positive or negative on next stage of testing and if fingers crossed positive what is the timescale for commercialisation . Thanks
I agree, potential here is huge and whilst time is of the essence, a small amount of patience is required. Whilst I’m more optimistic than ever before my only concern is the ability of management to get us over the finishing line based on sildenafil etc . Here’s hoping to be proven wrong and a huge future for N4P